Interviews

For prefilled drug delivery systems – from a syringe to a complex wearable – the main goal of the aseptic manufacturing process is to prevent contamination of the final product and ensure that it fits for its intended use....

1. Can you give a short introduction of yourself? My name is Stevanus Firman Kaligis, you can call me Steve. I am Global Leader of Procurement and my base is in Jakarta, Indonesia. I have a great interest in generating...

1) How can the end-to-end services of CAI help pharmaceutical companies to establish high standards of operational productivity and overall efficiency? CAI India is rapidly growing, having trained and recruited 21 agents in the past four months. Our company focuses...

Fast, safe and efficient: the new Vetter ID determination of oligonucleotides. Why is the analysis of oligonucleotides also a topic in the Analytical Science Laboratory (ASL)? MELANIE ZERULLA-WERNITZ: Oligonucleotides (from Greek oligo = few) are oligomers which consist of few nucleotides....

APAC’s relevance to a company as big as Vetter, a world leader in Contract Development & Manufacturing, has been significant, more so in recent years due to China’s strong footprint in the region. To dig in more on what...

Interview with Bernd Stauss, Senior Vice President Production/Engineering 1. What exactly is small scale batch manufacturing? The developments in the pharmaceutical world are diverse. Today, drugs are often developed for specific patient groups, right down to the individual. In this context,...

Q&A: FDA DSCSA Recall Pilot Program lessons learned Q: Can you update us on the FDA DSCSA Pilot Project programs TraceLink and its partners participated in now that the pilot projects have concluded? Ans: The DSCSA pilot project,launched in 2019, intended...